Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reid G Meyer

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Pathology|October 30, 2009
Automated cellular imaging system III for assessing HER2 status in breast cancer specimens: development of a standardized scoring method that correlates with FISHDouglas M Minot, Benjamin R Kipp, Renee M Root, et al.
Histopathology|September 27, 2019
Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testingJess F Peterson, Kathryn E Pearce, Reid G Meyer, et al.
Archives of Pathology & Laboratory Medicine|October 28, 2020
HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ HybridizationKatherine B Geiersbach, Daniel R Sill, Reid G Meyer, et al.
Journal of Hematopathology|July 15, 2025
Discovery of a germline IKZF1 deletion in a B-lymphoblastic leukemia post-induction bone marrow specimen: a case report and review of the literatureSharri Cyrus, Arun R Panigrahi, Alexia P Monahan, et al.
Blood Cancer Journal|January 15, 2020
High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?Priyanka A Pophali, Lisa M Marinelli, Rhett P Ketterling, et al.
Laboratory Medicine|November 18, 2021
Identification of a Cryptic t(8;20;21)(q22;p13;q22) Resulting in RUNX1T1/RUNX1 Fusion in a Patient with Newly Diagnosed Acute Myeloid LeukemiaErica L Macke, Reid G Meyer, Nicole L Hoppman, et al.
Laboratory Medicine|March 24, 2024
High-grade B-cell lymphoma with a quadruple-hit genetic profile including concurrent MYC, BCL2, BCL6, and CCND1 gene rearrangementsMarie-France Gagnon, Reid G Meyer, Eric J Weaver, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 25, 2003
Utility of subtelomeric fluorescent DNA probes for detection of chromosome anomalies in 425 patientsSyed M Jalal, Aaron R Harwood, Gurbax S Sekhon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists GuidelinesMithun Vinod Shah, Anne E Wiktor, Reid G Meyer, et al.
Genes, Chromosomes & Cancer|June 14, 2021
Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphomaJoanna C Dalland, James B Smadbeck, Neeraj Sharma, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Pathology|October 30, 2009
Automated cellular imaging system III for assessing HER2 status in breast cancer specimens: development of a standardized scoring method that correlates with FISHDouglas M Minot, Benjamin R Kipp, Renee M Root, et al.
Histopathology|September 27, 2019
Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testingJess F Peterson, Kathryn E Pearce, Reid G Meyer, et al.
Archives of Pathology & Laboratory Medicine|October 28, 2020
HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ HybridizationKatherine B Geiersbach, Daniel R Sill, Reid G Meyer, et al.
Journal of Hematopathology|July 15, 2025
Discovery of a germline IKZF1 deletion in a B-lymphoblastic leukemia post-induction bone marrow specimen: a case report and review of the literatureSharri Cyrus, Arun R Panigrahi, Alexia P Monahan, et al.
Blood Cancer Journal|January 15, 2020
High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?Priyanka A Pophali, Lisa M Marinelli, Rhett P Ketterling, et al.
Laboratory Medicine|November 18, 2021
Identification of a Cryptic t(8;20;21)(q22;p13;q22) Resulting in RUNX1T1/RUNX1 Fusion in a Patient with Newly Diagnosed Acute Myeloid LeukemiaErica L Macke, Reid G Meyer, Nicole L Hoppman, et al.
Laboratory Medicine|March 24, 2024
High-grade B-cell lymphoma with a quadruple-hit genetic profile including concurrent MYC, BCL2, BCL6, and CCND1 gene rearrangementsMarie-France Gagnon, Reid G Meyer, Eric J Weaver, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 25, 2003
Utility of subtelomeric fluorescent DNA probes for detection of chromosome anomalies in 425 patientsSyed M Jalal, Aaron R Harwood, Gurbax S Sekhon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists GuidelinesMithun Vinod Shah, Anne E Wiktor, Reid G Meyer, et al.
Genes, Chromosomes & Cancer|June 14, 2021
Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphomaJoanna C Dalland, James B Smadbeck, Neeraj Sharma, et al.
Pageof 4